Treating rheumatoid arthritis with new disease modifying drugs.

  title={Treating rheumatoid arthritis with new disease modifying drugs.},
  author={Martin Aringer and Winfried B. Graninger},
  journal={Acta medica Austriaca},
  volume={29 1},
Rheumatoid arthritis (RA) is a serious illness that can only be controlled by the appropriate use of disease modifying anti-rheumatic drugs (DMARDs). In spite of the successful use of such substances, and of methotrexate in particular, a large number of patients still experience disease progression. Leflunomide and the two anti-TNF agents, infliximab and etanercept, were therefore warmly greeted as very welcome additions to the rheumatologist's armamentarium. These successful newcomers, their… CONTINUE READING